[go: up one dir, main page]

MX2020002321A - Composición que contiene un análogo de kaempferol. - Google Patents

Composición que contiene un análogo de kaempferol.

Info

Publication number
MX2020002321A
MX2020002321A MX2020002321A MX2020002321A MX2020002321A MX 2020002321 A MX2020002321 A MX 2020002321A MX 2020002321 A MX2020002321 A MX 2020002321A MX 2020002321 A MX2020002321 A MX 2020002321A MX 2020002321 A MX2020002321 A MX 2020002321A
Authority
MX
Mexico
Prior art keywords
containing composition
composition
kaempferol
kaempferol analog
improving
Prior art date
Application number
MX2020002321A
Other languages
English (en)
Inventor
Yasutaka Ikeda
Tsubasa Mizokami
Yasuhiro Abiru
Minoru Akiyama
Ayuko Oyama
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of MX2020002321A publication Critical patent/MX2020002321A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A23L29/035—Organic compounds containing oxygen as heteroatom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/31—Foods, ingredients or supplements having a functional effect on health having an effect on comfort perception and well-being
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/316—Foods, ingredients or supplements having a functional effect on health having an effect on regeneration or building of ligaments or muscles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/20—Natural extracts
    • A23V2250/21—Plant extracts
    • A23V2250/2116—Flavonoids, isoflavones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Amplifiers (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)

Abstract

La presente solicitud proporciona una composición para mejorar la eficiencia de la actividad física, una composición para reducir la fatiga, y una composición para mejorar la agudeza visual dinámica/cinética, que comprende un análogo de kaempferol.
MX2020002321A 2017-08-30 2018-08-30 Composición que contiene un análogo de kaempferol. MX2020002321A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/JP2017/031214 WO2019043846A1 (ja) 2017-08-30 2017-08-30 ケンペロール類縁体含有組成物
PCT/JP2018/032104 WO2019044964A1 (ja) 2017-08-30 2018-08-30 ケンペロール類縁体含有組成物

Publications (1)

Publication Number Publication Date
MX2020002321A true MX2020002321A (es) 2020-10-05

Family

ID=65525082

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2020002321A MX2020002321A (es) 2017-08-30 2018-08-30 Composición que contiene un análogo de kaempferol.
MX2024008437A MX2024008437A (es) 2017-08-30 2020-02-28 Composicion que contiene un analogo de kaempferol.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2024008437A MX2024008437A (es) 2017-08-30 2020-02-28 Composicion que contiene un analogo de kaempferol.

Country Status (12)

Country Link
US (3) US20200323816A1 (es)
EP (1) EP3677262A4 (es)
JP (3) JP7372149B2 (es)
KR (1) KR20200050980A (es)
CN (1) CN111032037A (es)
AU (2) AU2018327188B2 (es)
BR (1) BR112020003933A2 (es)
CA (1) CA3073804A1 (es)
MX (2) MX2020002321A (es)
SG (1) SG11202001653QA (es)
TW (2) TWI845480B (es)
WO (2) WO2019043846A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019043846A1 (ja) 2017-08-30 2019-03-07 大塚製薬株式会社 ケンペロール類縁体含有組成物
KR20210131377A (ko) * 2019-02-27 2021-11-02 오츠카 세이야쿠 가부시키가이샤 식물 유래 추출물 및/또는 식물 유래 가공품 함유 조성물
JP7367956B2 (ja) * 2019-07-05 2023-10-24 国立大学法人大阪大学 動体視力向上用組成物
US20230321030A1 (en) * 2020-08-25 2023-10-12 Otsuka Pharmaceutical Co., Ltd. Kaempferol aglycone-containing extract
WO2022269931A1 (ja) * 2021-06-25 2022-12-29 大塚製薬株式会社 筋損傷抑制用組成物
KR102820457B1 (ko) 2022-09-26 2025-06-12 충북대학교 산학협력단 캠페롤 성분이 증가된 효소처리한 동백 종자 추출물을 포함하는 화장료 조성물 및 그의 제조방법

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60038302T2 (de) 1999-07-02 2009-04-23 Meiji Seika Kaisha Ltd. Zusammensetzungen fuer lebensmittel, verfahren zur herstellung derselben sowie diese enthaltende funktionelle lebensmittel und getraenke
US20060111318A1 (en) * 2003-04-18 2006-05-25 Advanced Medicine Research Institute Agent for treating eye diseases
JP2006298876A (ja) * 2005-04-25 2006-11-02 Saisentan Igaku Kenkyusho:Kk サーチュインの活性化剤を含む各種眼疾患治療用組成物
US20060222682A1 (en) 2005-03-18 2006-10-05 Andrews David A Nutraceutical Moringa composition
AU2006269459B2 (en) 2005-07-07 2013-02-07 Sirtris Pharmaceuticals, Inc. Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
CN101257897A (zh) * 2005-07-07 2008-09-03 西特里斯药业公司 用于治疗或预防肥胖、胰岛素抵抗障碍和线粒体相关障碍的方法和相关组合物
JP5066706B2 (ja) 2006-02-28 2012-11-07 国立大学法人徳島大学 抗肥満剤のスクリーニング方法
JP5061282B2 (ja) * 2006-07-10 2012-10-31 株式会社 伊藤園 ナリンゲニン誘導体、それを含有するグルコース取込み促進剤及び血糖値上昇抑制剤
JP5713332B2 (ja) * 2007-02-23 2015-05-07 ユニチカ株式会社 抗疲労用組成物
JP2009155333A (ja) 2009-01-13 2009-07-16 Tsujido Chemical Corp 抗疲労剤
WO2010086972A1 (ja) 2009-01-28 2010-08-05 Sekiyama Atsuo 抗ストレス剤
KR101177786B1 (ko) 2010-02-26 2012-08-30 박영주 꿀벌 화분 발효액, 프로폴리스, 벌꿀 및 로얄 제리를 함유하는 건강식품의 제조 방법
US9198453B2 (en) 2010-09-17 2015-12-01 Stokely-Van Camp, Inc. Methods of reducing blood lactate concentration
CN102600269A (zh) 2011-01-19 2012-07-25 江苏中康药物科技有限公司 一种含异长春花苷内酰胺的胆木叶组合物及其制剂与用途
CN102138998B (zh) 2011-04-08 2013-04-24 中国人民解放军总后勤部卫生部药品仪器检验所 枳椇子总黄酮提取物及其在制备抗疲劳、抗缺氧或抗高原缺氧药物或食品中的应用
JP2012236793A (ja) * 2011-05-11 2012-12-06 Kikkoman Corp Ａｍｐｋ活性化剤
US20140107193A1 (en) 2011-10-14 2014-04-17 Mead Johnson Nutrition Company Nutritional composition containing a neurologic component of kaempferol and/or fisetin and uses thereof
KR101454425B1 (ko) * 2012-10-11 2014-11-03 포항공과대학교 산학협력단 미리세틴을 유효성분으로 포함하는 운동수행능력 증강용 조성물
WO2014171333A1 (ja) 2013-04-17 2014-10-23 株式会社フローラ ミトコンドリア活性化剤
CN104223068B (zh) * 2014-09-05 2016-09-21 杨高林 一种补肝益肾明目的沙苑子口服液及其制备方法
WO2016149277A1 (en) * 2015-03-17 2016-09-22 Specialty Nutrition Group, Inc. Nutritional compositions to enhance mitochondrial energy production
HK1248591A1 (zh) * 2015-04-10 2018-10-19 奥力榨油化株式会社 肌肉細胞中的能量代謝激活劑
KR102160428B1 (ko) * 2015-09-23 2020-09-29 리옥신, 엘엘씨 플라보노이드 조성물 및 사용 방법
EP3360548A4 (en) 2015-10-08 2019-06-19 Productive Aging Laboratory, Co., Ltd. INHIBITOR OF MUSCLE DENSION OR MUSCLE FATIGUE
TW201733619A (zh) * 2015-12-16 2017-10-01 Suntory Holdings Ltd 肌肽二肽酶阻礙用組成物
WO2019043846A1 (ja) 2017-08-30 2019-03-07 大塚製薬株式会社 ケンペロール類縁体含有組成物
CN112568425A (zh) 2019-09-30 2021-03-30 中粮营养健康研究院有限公司 能量棒及其制备方法和在制备抗肌肉损伤的产品中的应用

Also Published As

Publication number Publication date
TW202435858A (zh) 2024-09-16
TW201912154A (zh) 2019-04-01
JP2023126878A (ja) 2023-09-12
US20240325348A1 (en) 2024-10-03
JPWO2019044964A1 (ja) 2020-10-08
TWI845480B (zh) 2024-06-21
AU2018327188A1 (en) 2020-03-19
JP2025081665A (ja) 2025-05-27
WO2019043846A1 (ja) 2019-03-07
EP3677262A4 (en) 2021-05-26
KR20200050980A (ko) 2020-05-12
BR112020003933A2 (pt) 2020-09-08
CA3073804A1 (en) 2019-03-07
AU2024216546A1 (en) 2024-09-19
US12048683B2 (en) 2024-07-30
EP3677262A1 (en) 2020-07-08
CN111032037A (zh) 2020-04-17
US20200323816A1 (en) 2020-10-15
US20210228540A1 (en) 2021-07-29
AU2018327188B2 (en) 2024-08-08
SG11202001653QA (en) 2020-03-30
MX2024008437A (es) 2024-07-19
JP7372149B2 (ja) 2023-10-31
WO2019044964A1 (ja) 2019-03-07
JP7642730B2 (ja) 2025-03-10

Similar Documents

Publication Publication Date Title
MX2024008437A (es) Composicion que contiene un analogo de kaempferol.
CR20190350A (es) INHIBIDORES DE TGFß1 ISOFORMA-ESPECÍFICOS CONTEXTO-PERMISIVOS Y USO DE LOS MISMOS
AR110684A1 (es) Composiciones que comprenden cepas bacterianas y método de tratamiento
UY35496A (es) Composiciones sinérgicas que comprenden una cepa de bacillus subtilis y un plaguicida
CL2018000963A1 (es) Cosmética que tiene bacterias probióticas
AR092418A1 (es) Metodo para aumentar la resistencia al estres abiotico de una planta
AR105434A1 (es) Proceso para preparar pridopidina
ECSP19072372A (es) Moduladores de la expresión de pcsk9
HK1216833A1 (zh) 組織擴張器、移植物及使用方法
MX2022006817A (es) Formulaciones/composiciones que comprenden un inhibidor de btk.
DOP2021000044A (es) Moduladores de la expresión de pnpla3
UY36332A (es) Composiciones de bacillus pumilus rt1279 y metodos de uso para benefficiar el crecimiento de las plantas
MX2017006953A (es) Medicamentos para disminuir la evolucion de la enfermedad de parkinson.
MX2017007000A (es) Composiciones que comprenden acido 15-hidroxieicosapentaenoico (15-hepe) y metodos para tratar o prevenir la fibrosis usando las mismas.
CL2021001246A1 (es) Moduladores de expresión irf5.
BR112021016883A2 (pt) Composição contendo extrato derivado de planta e/ou produto processado derivado de planta
MX2019013251A (es) Una composicion nutricional para usarse para mejorar la atencion y/o reducir la impulsividad.
MX2017013879A (es) Composiciones que comprenden anakinra.
CL2019003234A1 (es) Formulación de alcohol estearílico.
CO2020003134A2 (es) Moduladores de la expresión de enac
CL2015001481A1 (es) Uso de extracto bacopa monnieri
AR110094A1 (es) Método para preparar d-psicosa utilizando microorganismos del género kaistia
CL2018003901A1 (es) Composición biológica con actividad fungicida sinérgica y un método de aplicación de la misma
CL2018002572A1 (es) Microorganismo productor de putrescina y procedimiento para producir putrescina usando el mismo
AR109374A1 (es) Composición para el tratamiento de superficies duras